Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate ...

When tissue is severely damaged, surviving cells can respond in a concentrated burst of biological repair known as ...

Metacaspases, ancestral homologues of the caspase family, are pivotal cysteine proteases found in a wide range of unicellular organisms, including yeasts, algae, and phytoplankton. These enzymes ...

AbbVie and RemeGen are collaborating on RC148, a novel PD-1/VEGF-targeted bispecific antibody already being developed as a ...

US pharma major AbbVie and China’s RemeGen today announced an exclusive licensing agreement for the development, ...

A recent study links chemotherapy to impaired ovarian function and fertility through oxidative damage to ovarian follicles.

Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) ...

A new study reveals how a single cancer protein may simultaneously drive tumor survival and metabolic control, uncovering a hidden link between two core features of cancer. Scientists have uncovered a ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

AbbVie & RemeGen enter exclusive licensing agreement to develop novel bispecific antibody for advanced solid tumours: North Chicago, Illinois Tuesday, January 13, 2026, 14:00 Hrs ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...